A coxib a day won't keep the doctor away

被引：63

作者：

Topol, EJ

Falk, GW

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

[2] Cleveland Clin Fdn, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA

来源：

LANCET | 2004年 / 364卷 / 9435期

关键词：

D O I：

10.1016/S0140-6736(04)16906-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：639 / 640

页数：2

共 18 条

[1] Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein - A randomized placebo-controlled study
Bogaty, P
Brophy, JM
Noel, M
Boyer, L
Simard, S
Bertrand, F
Dagenais, GR
[J]. CIRCULATION, 2004, 110 (08) : 934 - 939
[2] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
Bombardier, C
Laine, L
Reicin, A
Shapiro, D
Burgos-Vargas, R
Davis, B
Day, R
Ferraz, MB
Hawkey, CJ
Hochberg, MC
Kvien, TK
Schnitzer, TJ
Weaver, A
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
[3] Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis
Chan, FKL
Hung, LCT
Suen, BY
Wu, JCY
Lee, KC
Leung, VKS
Hui, AJ
To, KF
Leung, WK
Wong, VWS
Chung, SCS
Sung, JJY
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (26) : 2104 - 2110
[4] Selective COX-2 inhibition improves endothelial function in coronary artery disease
Chenevard, R
Hürlimann, D
Béchir, M
Enseleit, F
Spieker, L
Hermann, M
Riesen, W
Gay, S
Gay, RE
Neidhart, M
Michel, B
Lüscher, TF
Noll, G
Ruschitzka, F
[J]. CIRCULATION, 2003, 107 (03) : 405 - 409
[5] Cyclooxygenase-2 expression and inhibition in atherothrombosis
Cipollone, F
Rocca, B
Patrono, C
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (02) : 246 - 255
[6] COX-2 and beyond: Approaches to prostaglandin inhibition in human disease
FitzGerald, G
[J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (11) : 879 - 890
[7] Therapeutic Arthritis Research and Gastrointestinal Event Trial of lumiracoxib - study design and patient demographics
Hawkey, CJ
Farkouh, M
Gitton, X
Ehrsam, E
Huels, J
Richardson, P
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (01) : 51 - 63
[8] Nonsteroidal anti-inflammatory drugs and cardiovascular risk
Howard, PA
Delafontaine, P
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) : 519 - 525
[9] Are selective COX 2 hihibitors superior to traditional non steroidal anti-inflammatory drugs?: Adequate analysis of the CLASS trial indicates that this may not be the case
Jüni, P
Rutjes, AWS
Dieppe, PA
[J]. BRITISH MEDICAL JOURNAL, 2002, 324 (7349): : 1287 - 1288
[10] Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study
Mamdani, M
Juurlink, DN
Kopp, A
Naglie, G
Austin, PC
Laupacis, A
[J]. BRITISH MEDICAL JOURNAL, 2004, 328 (7453): : 1415 - 1416

← 1 2 →